Drug
Triple Fixed Dose Combination
Triple Fixed Dose Combination: highest development phase Not Applicable, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Triple Fixed-Dose Combination (Perindoprile/Indapamide/Amlodipine) NCT07259733 | Not Applicable | Apparent Resistant Hypertension |
Latest
No recent events.
Follow Triple Fixed Dose Combination on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.